drugset / Trial / NCT01574612

Open Label Safety Study of Xerese Cream in the Treatment of Recurrent Herpes Labialis in Children 6-11 Years Old

NCT01574612

Phase 3 Completed 54 enrolled Meda Pharmaceuticals TKL Research, Inc. · collab
NaSingle-groupOpen-labelTreatment

Summary

To test the safety of Xerese (acyclovir and hydrocortisone)Cream 5%/1% for the treatment of recurrent cold sores in children ages 6-11yrs after 5 days of treatment.

Timeline

Start
2012-03
Primary completion
2012-12
Completion
2013-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Acyclovir Small molecule 5 % Topical
Subject Hydrocortisone Other / unclassified 1 % Topical

Indications